# An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)

> clinical trial · VERIFIED · 2026-08-31

Status: ACTIVE_NOT_RECRUITING · Sponsor: Aragon Pharmaceuticals, Inc. · Condition: Prostatic Neoplasms

- Company: Aragon Pharmaceuticals, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT02257736

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.